Zhihua Yang

Dr. Zhihua Yang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Brain Research Bulletin
Verified
Journal Article
Open access
ZLZhangrong Li
Zhangrong Li
HYHuiling Ye
Huiling Ye
XCXueli Cai
Xueli Cai
WSWeiwen Sun
Weiwen Sun
BHBin He
Bin He
PXPingyi Xu
Pingyi Xu
Bone marrow-mesenchymal stem cells (BM-MSCs) possess immunomodulatory properties in the brain. However, it remains unclear whether intravenously transplanted BM-MSCs have a neuromodulator effect on the activation of microglias after ischemic stroke. This study aimed to investigate the immunomodulatory effect of BM-MSCs on the regulation of brain microglial inactivation during the acute phase of stroke. A rat model of middle cerebral artery occlusion (MCAO) was established. Rat BM-MSCs were transplanted through the tail vein at 12 h after MCAO. CD200 Receptor 1 (CD200R1) antibody was injected into the peri-infarct area of the rat brain at 3 h prior to BM- MSCs transplantation. Protein expression was determined by immunofluorescence staining and Western blot. The volume of the infarct area was determined by TTC (2,3,5-triphenyltetrazolium hydrochloride) staining. Neuron apoptosis was determined by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. In vitro study showed that co-culture with BM-MSCs significantly decreased LPS-induced iNOS expression in the microglial cells. Immunofluorescence and Western blot consistently revealed that BM-MSC transplantation significantly reduced the IBA-expressing microglial cells and IBA protein levels in the peri-infarct area. The inhibitory effect of BM-MSC on IBA expression was significantly attenuated by pretreatment of CD200R1 neutralizing antibody in the peri-infarct zone. BM-MSC transplantation significantly reduced the infarct volume, protected neuron apoptosis, and increased neuronal CD200 expression in the peri-infarct area. The transplanted BM-MSCs exerted immunomodulatory effect by inactivating the microglias in the peri-infarct area, at least partially, via the CD200-CD200R1 signaling.

1 December 2016 in Cell Transplantation
Verified
Journal Article
Open access
BHBin He
Bin He
QYQianmin Yao
Qianmin Yao
ZLZijing Liang
Zijing Liang
JLJunmin Lin
Junmin Lin
YXYubao Xie
Yubao Xie
PXPingyi Xu
Pingyi Xu
The therapeutic benefits of bone marrow-derived mesenchymal stem cell (BM-MSC) transplantation for ischemic stroke have been extensively demonstrated. However, studies on the optimal cell dose for intravenous administration are still limited. This study aimed to determine an appropriate cell dose for BM-MSC intravenous transplantation and to investigate the effect of cell dose on vascular remodeling in a rat model of ischemic stroke. BM-MSCs at doses of 5 × 10 4 (low-dose group), 5 × 10 5 (medium-dose group), and 2 × 10 6 (high-dose group) were intravenously injected into rats at 72 h after ischemia. The therapeutic efficacy of BM-MSCs was evaluated by measuring infarct volume, vascular diameters, capillary area in the peri-infarct zone, level of basic fibroblast growth factor (bFGF) in the peri-infarct zone, and serum vascular endothelial growth factor (VEGF) level at 7 days after ischemia. Compared with the low-dose and control groups, medium-dose and high-dose BM-MSC transplantation significantly reduced the volume of the infarct area, enlarged the diameters of pial vessels and the basilar artery, and increased the capillary area in the peri-infarct zone of the cerebral cortex. Furthermore, transplanted BM-MSCs elevated the expressions of bFGF in the peri-infarct zone and the serum VEGF level. Administration of 5 × 10 5 BM-MSCs is an appropriate cell dose for ischemic stroke therapy in rats. These findings may be helpful for designing future clinical trials.

25 March 2015
Verified
Book Chapter
Open access
PDF file
ZYZhihua Yang
Zhihua Yang
SBShoumin Bai
Shoumin Bai
BGBeibei Gu
Beibei Gu
SPShuling Peng
Shuling Peng
WLWang Liao
Wang Liao
JLJun Liu
Jun Liu

14 October 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
JXJian Xu
Jian Xu
ZYZhihua Yang
Zhihua Yang
RWRui Wang
Rui Wang
FHFumei He
Fumei He
RYRong Yan
Rong Yan
YNYichu Nie
Yichu Nie
Transcription factors (TFs) have been introduced to drive the highly efficient differentiation of human-induced pluripotent stem cells (hiPSCs) into lineage-specific oligodendrocytes (OLs). However, effective strategies currently rely mainly on genome-integrating viruses. Here we show that a synthetic modified messenger RNA (smRNA)-based reprogramming method that leads to the generation of transgene-free OLs has been developed. An smRNA encoding a modified form of OLIG2, in which the serine 147 phosphorylation site is replaced with alanine, OLIG2S147A, is designed to reprogram hiPSCs into OLs. We demonstrate that repeated administration of the smRNA encoding OLIG2S147A lead to higher and more stable protein expression. Using the single-mutant OLIG2 smRNA morphogen, we establish a 6-day smRNA transfection protocol, and glial induction lead to rapid NG2+ OL progenitor cell (OPC) generation (>70% purity) from hiPSC. The smRNA-induced NG2+ OPCs can mature into functional OLs in vitro and promote remyelination in vivo. Taken together, we present a safe and efficient smRNA-driven strategy for hiPSC differentiation into OLs, which may be utilized for therapeutic OPC/OL transplantation in patients with neurodegenerative disease.

19 May 2023 in Research Square
Verified
Preprint
Open access
PDF file
PXPeishan Xia
Peishan Xia
LYLiying Yu
Liying Yu
BHBin He
Bin He
YPYuhua Pan
Yuhua Pan
JXJian Xu
Jian Xu
ZYZhihua Yang
Zhihua Yang
Purpose The objective of this study was to investigate the connection between circular RNA (circRNA) and ischemia-reperfusion (I/R) injury set on by middle cerebral artery occlusion (MCAO) in different parts of the rat brain. Methods Using the MCAO technique, the adult male Sprague-Dawley rat model was created. At 24 hours after reperfusion, circRNA sequencing and real-time PCR were used to assess the circRNA expression profile in the ischemic region of the right cortex, striatum, and hippocampus. A bioinformatics investigation of the changed circRNAs following I/R injury was carried out, including the discovery of miRNA binding sites, analysis of transcription factor binding, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Gene Ontology (GO) analysis. Results 85, 113 and 51 circRNAs in the cortex, striatum and hippocampus, respectively, substantially altered (|log2 (fold change)| > 1 and P < 0.05) after I/R, compared with the sham group. Significantly changed circRNAs found by sequencing analysis were confirmed by real-time PCR. Target genes of dysregulated circRNAs were connected to cellular components, biological processes, and molecular functions after I/R, according to GO and KEGG pathway studies. Finally, we successfully predicted a circMapk9-miR-29a-5p-gene network connected with NLRP3-mediated neuroinflammation in I/R. Conclusion The findings of this work provide the first investigation into the association between circRNAs and I/R injury brought on by MCAO in different parts of the rat brain, as well as a novel molecular target for the therapeutic management of I/R injury following endovascular thrombectomy (EVT).

3 November 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
JXJian Xu
Jian Xu
ZYZhihua Yang
Zhihua Yang
RWRui Wang
Rui Wang
FHFumei He
Fumei He
RYRong Yan
Rong Yan
YNYichu Nie
Yichu Nie